Wordt geladen...
A common feature pharmacophore for FDA-approved drugs inhibiting the Ebola virus
We are currently faced with a global infectious disease crisis which has been anticipated for decades. While many promising biotherapeutics are being tested, the search for a small molecule has yet to deliver an approved drug or therapeutic for the Ebola or similar filoviruses that cause haemorrhagi...
Bewaard in:
| Gepubliceerd in: | F1000Res |
|---|---|
| Hoofdauteurs: | , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
F1000Research
2014
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4304229/ https://ncbi.nlm.nih.gov/pubmed/25653841 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12688/f1000research.5741.2 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|